Anyone else seeing whispers about Biogen layoffs? Aduhelm price cut seems like a bad sign

Hey everyone, Seeing a lot of chatter about Biogen, especially with that Aduhelm price cut. Honestly, that feels like a pretty desperate move, and it's making me nervous about job security here. Haven't heard anything concrete on the internal channels, but the rumors seem to be picking up steam. It's hard not to connect the dots between a major drug's reduced value and potential cost-cutting measures. Is anyone else in a similar boat? Heard anything more specific, even if it's just hallway gossip? Curious if it's department-specific or a broader shake-up they might be planning. Just trying to get a sense of what's really going on beyond the official statements. Trying to stay calm but it's tough when you see these kinds of financial moves.